arrow
O

Olga Kondrashova

QIMR Berghofer Medical Research Institute
H指数:22
被引数:2,785

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Olaparib in HR-deficient, metastatic triple-negative breast and platinum-sensitive relapsed ovarian cancers without germline mutations in BRCA1/2: phase 2 EMBRACE trial

奥拉帕利在HR缺陷、转移性三阴性乳腺癌和铂敏感复发性卵巢癌中BRCA1/2无胚系突变患者中的疗效:EMBRACE二期临床试验

2026-07-080
OA
Mapping the Proteomic Landscape of Pancreatic Cancer: Prognostic Insights and Subtype Stratification

绘制胰腺癌的蛋白质组学图谱:预后见解与亚型分层

2025-10-010
OA
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
2024-08-050
OAAI
The microtubule inhibitor eribulin demonstrates efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models

微管抑制剂eribulin在铂耐药和难治性高级浆液性卵巢癌患者来源的异种移植模型中显示出疗效

2023-11-221
OAAI
Performance of tumour microenvironment deconvolution methods in breast cancer using single-cell simulated bulk mixtures

使用单细胞模拟散装混合物在乳腺癌中肿瘤微环境去卷积方法的性能

2023-09-1613
OAAI
Multi-omic features of oesophageal adenocarcinoma in patients treated with preoperative neoadjuvant therapy
2023-05-319
OAAI
Heritable defects in telomere and mitotic function selectively predispose to sarcomas
Science
IF45.8
2023-01-010
OA
Epithelial-to-Mesenchymal Transition Supports Ovarian Carcinosarcoma Tumorigenesis and Confers Sensitivity to Microtubule Targeting with Eribulin
2022-10-0710
OAAI
Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels

全基因组测序、基于计算机的全外显子组测序及突变Panel在癌症基因组中检测到的可靶向事件比较

2022-08-0112
OAAI
Comprehensive genomic and tumour immune profiling reveals potential therapeutic targets in malignant pleural mesothelioma

全面的基因组和肿瘤免疫分析揭示了恶性胸膜间皮瘤的潜在治疗靶点

2022-05-3029
OAAI
Patient-derived xenograft models capture genomic heterogeneity in endometrial cancer

患者来源的异种移植模型捕获了子宫内膜癌的基因组异质性

2022-01-1021
OAAI